Evidence map›Paper›PMID 32735845›Full record

ArticleImmunity2020

Differential IRF8 Transcription Factor Requirement Defines Two Pathways of Dendritic Cell Development in Humans.

Urszula Cytlak, Anastasia Resteu, Sarah Pagan, Kile Green, Paul Milne, Sheetal Maisuria, David McDonald, Gillian Hulme, Andrew Filby, Benjamin Carpenter and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Immunity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 146 papers.

0numbers the graph read from it
0cells of the map it votes in
146citing papers in PubMed
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

146 citing papers in PubMed, 239 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

86 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 2 countries.

Urszula CytlakTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Anastasia ResteuTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Sarah PaganTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Kile GreenTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Paul MilneTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Sheetal MaisuriaInstitute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds LS9 7TF, UK.
David McDonaldBiosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Gillian HulmeBiosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Andrew FilbyBiosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Benjamin CarpenterOxford Genomics Centre, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.
Rachel QueenBiosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Sophie HambletonTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE1 4LP, UK.
Rosie HagueDepartment of Paediatric Immunology and Infectious Diseases, Royal Hospital for Children, Glasgow G51 4TF, UK.
Hana Lango AllenDepartment of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0SP, UK; NIHR BioResource, Cambridge University Hospitals, Cambridge Biomedical Campus, Cambridge CB2 0SP, UK.
James E D ThaventhiranMRC Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge CB2 1QR, UK.
Gina DoodyLeeds Institute of Medical Research, University of Leeds, Leeds LS9 7TF, UK.
Matthew CollinTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK; Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE7 7DN, UK.
Venetia BigleyTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK; Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE7 7DN, UK. Electronic address: venetia.bigley@ncl.ac.uk.
Newcastle University · GBNewcastle upon Tyne Hospitals NHS Foundation Trust · GBUniversity of Cambridge · GBUniversity of Leeds · GBCentre for Human Genetics · GBRoyal Hospital for Children · GB

Funding

Cancer Research UK 21025Cancer Research UK C30484/A21025Wellcome Trust 101155/Z/13/Z
6 · The paper itself

Abstract

The formation of mammalian dendritic cells (DCs) is controlled by multiple hematopoietic transcription factors, including IRF8. Loss of IRF8 exerts a differential effect on DC subsets, including plasmacytoid DCs (pDCs) and the classical DC lineages cDC1 and cDC2. In humans, cDC2-related subsets have been described including AXL

Indexed as

AnimalsAntigens, CD1Antigens, CD34Cell LineCell LineageDendritic CellsGlycoproteinsHematopoiesisHematopoietic Stem CellsHumansInterferon Regulatory Factor-8Interferon Regulatory FactorsInterleukin-3 Receptor alpha SubunitLipopolysaccharide ReceptorsMiceReceptors, ImmunologicAntigens, CD1Antigens, CD34BTLA protein, humanCD14 protein, humanCD1C protein, humanGlycoproteinsIL3RA protein, humanInterferon Regulatory Factor-8Interferon Regulatory FactorsInterleukin-3 Receptor alpha SubunitLipopolysaccharide ReceptorsReceptors, ImmunologicCyTOFdendritic cellhematopoiesisimmunityIRF8primary immunodeficiencysingle-cell RNA sequencingtranscription factor

Identifiers

PMID32735845
PMCPMC7447982
OpenAlexW3039712726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.